AVELOX
Description
AVELOX IV
Composition:
Moxifloxacin Hydrochloride 436.80mg equiv to 400mg in 250ml of sterile sol for infusion.
Therapeutic Action:
Antibacterial.
Indications:
Treatment of infections caused by germs sensitive to moxifloxacin.
Avelox IV is indicated for the treatment of adults (> 18 years old) with upper and lower respiratory infections such as: acute sinusitis; acute exacerbations of chronic bronchitis; community-acquired pneumonia, as well as skin and soft tissue infections.
Posology:
400mg (1 tablet or 1 bag x 60 min) 1 v / day in all indications. Usually for upper and lower respiratory tract. Acute exacerbation of chronic bronchitis 5 days. Community acquired pneumonia 7-14 days. Acute sinusitis 7 days. Recommended treatment duration for skin and soft tissue infections 7 days.
Contraindication:
Hypersensitivity to quinolones. Pregnancy and breastfeeding. Patients <18 years of age, due to the fact that quinolones have caused irreversible joint damage in toxicological studies.
Manufacturer:
Bayer.
Reviews
There are no reviews yet.